Loading...

Procaps Group, S.A.

PROCW•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.02
$0.005(33.79%)

Procaps Group, S.A. (PROCW) AI-Powered Stock Analysis

See how Procaps Group, S.A. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Procaps Group, S.A. (PROCW) Stock Overall Grade

Procaps Group, S.A.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

B

Good

Grade Breakdown by Metric

See how each financial and market factor contributes to Procaps Group, S.A.'s overall stock rating.

Forecast

C+

Score

50/100

Financial Growth

C

Score

40/100

Fundamental Growth

C+

Score

50/100

Key Ratios

B+

Score

70/100

Sector Comparison

B+

Score

75/100

Industry Comparison

B+

Score

75/100

S&P 500 Benchmark

A

Score

85/100

Analyst Consensus

C+

Score

50/100

Component Analysis Explained

Understand the key factors behind each Procaps Group, S.A. stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions

;